| |
| |
|
| Insider
Information: |
El Coronado Holdings, Llc |
| Relationship: |
10% Owner |
| City: |
Pearce |
| State: |
AZ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
6,674,725 |
|
|
Indirect Shares
|
27,131,085 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$10,998,072 |
|
|
| Total
Shares |
33,805,810 |
|
|
| Total
Value |
$10,998,072 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Nmi Health Inc |
NANM |
10% Owner |
2005-03-02 |
0 |
2009-06-22 |
9,805,857 |
Premium* |
|
|
Novogen Limited (ADR) |
NVGN |
10% Owner |
2006-04-21 |
0 |
2013-11-05 |
385,749 |
Premium* |
|
|
Chelsea Therapeutics Internation... |
CHTP |
10% Owner |
2007-03-22 |
0 |
2012-12-17 |
6,432,673 |
Premium* |
|
|
MEI Pharma Inc |
MEIP |
10% Owner |
2012-12-03 |
0 |
2012-12-03 |
3,832,081 |
Premium* |
|
|
Protea Biosciences Group Inc |
PRGB |
10% Owner |
2013-12-30 |
6,674,725 |
2013-12-30 |
6,674,725 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PRGB |
Protea Biosciences Group ... |
10% Owner |
– – • |
2012-12-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,136,044 |
|
- |
|
| PRGB |
Protea Biosciences Group ... |
10% Owner |
– – • |
2012-12-10 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,136,044 |
|
- |
|
| PRGB |
Protea Biosciences Group ... |
10% Owner |
– – • |
2013-03-21 |
4 |
B |
$0.50 |
$685,000 |
D/D |
1,370,000 |
3,506,044 |
2.45 |
- |
|
| PRGB |
Protea Biosciences Group ... |
10% Owner |
– – • |
2013-03-21 |
4 |
B |
$0.50 |
$685,000 |
I/I |
1,370,000 |
3,506,044 |
1.5 |
- |
|
| PRGB |
Protea Biosciences Group ... |
10% Owner |
– – • |
2013-04-05 |
4 |
B |
$0.50 |
$140,000 |
D/D |
280,000 |
3,786,044 |
2.45 |
- |
|
| PRGB |
Protea Biosciences Group ... |
10% Owner |
– – • |
2013-04-05 |
4 |
B |
$0.50 |
$140,000 |
I/I |
280,000 |
3,786,044 |
1.5 |
- |
|
| PRGB |
Protea Biosciences Group ... |
10% Owner |
– – • |
2013-06-30 |
4 |
B |
$0.50 |
$131,202 |
D/D |
262,403 |
4,048,447 |
2.45 |
- |
|
| PRGB |
Protea Biosciences Group ... |
10% Owner |
– – • |
2013-06-30 |
4 |
B |
$0.50 |
$131,202 |
I/I |
262,403 |
4,048,447 |
1.5 |
- |
|
| PRGB |
Protea Biosciences Group ... |
10% Owner |
– – • |
2013-11-01 |
5 |
B |
$0.50 |
$1,185,847 |
I/I |
2,371,694 |
6,420,141 |
0 |
- |
|
| PRGB |
Protea Biosciences Group ... |
10% Owner |
– – • |
2013-11-01 |
5 |
B |
$0.50 |
$1,185,847 |
D/D |
2,371,694 |
6,420,141 |
0 |
- |
|
| PRGB |
Protea Biosciences Group ... |
10% Owner |
– – • |
2013-11-01 |
4 |
B |
$0.50 |
$1,185,847 |
I/I |
2,371,694 |
6,420,141 |
1.5 |
- |
|
| PRGB |
Protea Biosciences Group ... |
10% Owner |
– – • |
2013-11-01 |
4 |
B |
$0.50 |
$1,185,847 |
D/D |
2,371,694 |
6,420,141 |
2.45 |
- |
|
| PRGB |
Protea Biosciences Group ... |
10% Owner |
– – • |
2013-12-30 |
4 |
B |
$0.50 |
$127,292 |
I/I |
254,584 |
6,674,725 |
1.5 |
- |
|
| PRGB |
Protea Biosciences Group ... |
10% Owner |
– – • |
2013-12-30 |
4 |
B |
$0.50 |
$127,292 |
D/D |
254,584 |
6,674,725 |
2.45 |
- |
|
| PRGB |
Protea Biosciences Group ... |
10% Owner |
– – • |
2013-12-30 |
5 |
B |
$0.50 |
$127,292 |
I/I |
254,584 |
6,674,725 |
0 |
- |
|
| PRGB |
Protea Biosciences Group ... |
10% Owner |
– – • |
2013-12-30 |
5 |
B |
$0.50 |
$127,292 |
D/D |
254,584 |
6,674,725 |
0 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2006-04-21 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,500) |
2,092,942 |
|
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2006-05-09 |
4 |
B |
$12.47 |
$62,350 |
I/I |
5,000 |
2,097,942 |
1.5 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2006-05-10 |
4 |
B |
$12.33 |
$124,533 |
I/I |
10,100 |
2,108,042 |
1.5 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2006-05-22 |
4 |
B |
$10.05 |
$49,230 |
I/I |
4,900 |
2,112,942 |
1.5 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2006-05-23 |
4 |
B |
$9.87 |
$59,220 |
I/I |
6,000 |
2,118,942 |
1.5 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2006-05-24 |
4 |
B |
$9.90 |
$23,374 |
I/I |
2,361 |
2,121,303 |
1.5 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2006-05-30 |
4 |
B |
$9.85 |
$19,700 |
I/I |
2,000 |
2,123,303 |
1.5 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2006-05-31 |
4 |
B |
$9.75 |
$10,725 |
I/I |
1,100 |
2,124,403 |
1.5 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2006-06-01 |
4 |
B |
$9.86 |
$9,495 |
I/I |
963 |
2,125,366 |
1.5 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
